Drugs / CX717
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03375021 | Jul 2005 → Jan 2006 | attention deficit-hyperactivity disorder | RespireRx | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CX717 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03375021 ↗ |
| Modality | Small molecule | — CHEMBL4791762 ↗ |